Advitech Solutions, Quebec, Canada, has entered into an exclusive agreement with Pierre Jouan Biotechnologie SA of France. This agreement gives Advitech exclusive rights to the technology that Jouan Biotechnologie has developed for applications for the treatment of psoriasis and other similar immune system disorders and covers, among others, the North American and Japanese markets. The French technology is based on the activity of bioactive peptides obtained from an enriched whey protein fraction and uses a patent-pending process. Advitech will apply this technology to its program for the development of a nutraceutical solution for psoriasis.